Precision medicine in pancreatic cancer: treating every patient as an exception
Author:
Publisher
Elsevier BV
Subject
Gastroenterology,Hepatology
Reference50 articles.
1. Cancer statistics, 2019;Siegel;CA Cancer J Clin,2019
2. 2564 resected periampullary adenocarcinomas at a single institution: trends over three decades;He;HPB (Oxford),2014
3. Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial;Oettle;JAMA,2013
4. FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer;Conroy;N Engl J Med,2018
5. Developments in metastatic pancreatic cancer: is gemcitabine still the standard?;Ying;World J Gastroenterol,2012
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A central research portal for mining pancreatic clinical and molecular datasets and accessing biobanked samples;2024-07-26
2. Clinical Relevance of Cancerization of Ducts in Resected Pancreatic Ductal Adenocarcinoma;Pancreas;2024-07
3. Personalized Medicine in Pancreatic Cancer: The Promise of Biomarkers and Molecular Targeting with Dr. Michael J. Pishvaian;Cancers;2024-06-26
4. Genomic determinants of biological aggressiveness and poor prognosis of pancreatic cancers: KRAS and beyond;Expert Review of Molecular Diagnostics;2024-05-03
5. KRAS Mutation Detection with (2S,4R)-4-[18F]FGln for Noninvasive PDAC Diagnosis;Molecular Pharmaceutics;2024-03-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3